Verndari, Inc. is a Northern-California based, privately held biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccine delivery to prevent known and emerging infectious diseases.

Capital investments in our company have supported Verndari’s mission to transform global health through next generation science and technology.

For further information on investing in Verndari, please email:

Scroll to Top